Scholarlink

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and is the fifth most common cancer in men and the seventh most common cancer in women worldwide [1]. Men are more commonly affected than women. The male-to-female ratio has been reported to vary regionally from 2:1 to 4:1 [2], with an overall male-to-female ratio of 2.4:1. In the United States, the incidence rates of liver cancer per 100,000 person-years are 2.0 for women and 3.7 for men, with a male-to-female ratio of 2.83:1.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hepatocellular Carcinoma: Staging and Clinical Management

  • 章节

  • 发表日期：

    2026年

查看全文
  • K. V. Narayanan Menon,
  • Arvind R. Murali,
  • Baljendra S. Kapoor,
  • Federico Aucejo

摘要

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and is the fifth most common cancer in men and the seventh most common cancer in women worldwide [1]. Men are more commonly affected than women. The male-to-female ratio has been reported to vary regionally from 2:1 to 4:1 [2], with an overall male-to-female ratio of 2.4:1. In the United States, the incidence rates of liver cancer per 100,000 person-years are 2.0 for women and 3.7 for men, with a male-to-female ratio of 2.83:1.